Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule ...

Novo Nordisk partners with U.S. biotech Septerna in a $2.2 billion deal to develop oral small molecule drugs for obesity and ...

During his trip to the Middle East, President Donald Trump met with Syria's president on Wednesday in the first face-to-face between the leaders of those two countries in 25 years, announcing that ...